| 10/12/2010 | BKCVHY | Moody's may lift King Pharmaceuticals
|
| 5/14/2010 | BK | King Pharmaceuticals completes $500 million revolving credit facility
|
| 5/11/2010 | BKCVHY | S&P affirms King, rates loan BBB-
|
| 5/6/2010 | BK | King Pharmaceuticals to get $500 million revolving credit facility
|
| 4/28/2010 | BKCVHY | Moody's rates King Pharmaceuticals loans Ba1
|
| 11/5/2009 | BK | King Pharmaceuticals pays down entire $28.7 million term loan
|
| 8/6/2009 | BK | King Pharmaceuticals repays $102.1 million of revolver borrowings
|
| 5/11/2009 | BKBWCVHY | King Pharmaceuticals repays $48 million of debt in first quarter
|
| 1/7/2009 | BK | Moody's ups King Pharma loans to Ba2
|
| 12/22/2008 | BK | Market Commentary: LCDX, cash steady, shrugging off stock dip; Ford, GM hold firm
|
| 12/16/2008 | BK | Market Commentary: Precision Drilling zeroing in on carve-out details; King Pharmaceuticals trims term loan; LCDX rises
|
| 12/16/2008 | BK | King Pharmaceuticals downsizes term loan to $200 million
|
| 12/2/2008 | BK | Market Commentary: Ford, GM rev higher as plans submitted to Congress; Banks could be the ticket for King Pharmaceuticals
|
| 12/1/2008 | BK | Market Commentary: King Pharmaceuticals may see OID widen; GM, Ford head higher; Cash, LCDX slide
|
| 11/20/2008 | BK | King Pharmaceuticals reworks deal, launches as $300 million term loan talked at Libor plus 500 bps
|
| 11/20/2008 | BK | Market Commentary: Autos drop as bailout hits glitch; Cash, LCDX fall; Aquilex tweaks deal; King launches with new structure
|
| 11/17/2008 | BK | King Pharmaceuticals delays $1 billion credit facility launch till Thursday
|
| 11/17/2008 | BK | Market Commentary: King resets launch; Chanticleer commitment expires; Pipeline Data fades away; Cash, LCDX fall
|
| 11/14/2008 | BK | King Pharmaceuticals to launch $1 billion credit facility on Tuesday
|
| 9/29/2008 | BKCV | S&P assigns King loan BBB-, convertibles BB
|
| 9/26/2008 | BK | Market Commentary: Fresenius Kabi widens OID, breaks for trading; Cash sees shortage of buyers; LCDX holds steady
|
| 9/25/2008 | BKCV | Moody's rates King Pharma loans Ba2
|
| 9/17/2008 | BK | King Pharmaceuticals details $1 billion credit facility for Alpharma bid
|
| 8/25/2008 | BKCV | Moody's affirms King
|
| 6/30/2008 | BKCV | S&P cuts King outlook to negative
|
| 5/21/2008 | BKCV | Moody's rates King Pharma SGL-1
|
| 9/21/2006 | BKBTCVHY | Moody's revises ratings for nine U.S. pharma companies
|
| 9/29/2005 | BKBTCV | S&P affirms King Pharmaceuticals, off watch
|
| 4/21/2005 | BKCV | Moody's confirms King Pharmaceuticals
|
| 2/28/2005 | BKCV | S&P cuts King Pharma view to negative
|
| 12/14/2004 | BKCV | S&P: King Pharma watch to developing
|
| 12/1/2004 | BKCV | Moody's cuts King Pharma loan to Ba2, converts to Ba3
|
| 7/26/2004 | BKCV | Moody's: King Pharma uncertain
|
| 7/26/2004 | BKCV | S&P: King Pharma on positive watch
|
| 7/13/2004 | BKCV | S&P lowers King Pharma
|
| 2/11/2003 | BK | Moody's cuts El Paso
|
| 1/30/2003 | BK | S&P raises Lennar to investment grade
|
